Considering both transcriptional and post-translational mechanisms of action, we found that 17-DMAG treatment caused changes in the transcriptional regulation of the translocated MYC gene in Burkitt lymphoma cells, revealing a shift from active to inactive chromatin structure. The gene discussed is MYC; the disease is Burkitt lymphoma.